Frazier Life Sciences Management, L.P. Mirum Pharmaceuticals, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.67 Billion
- Q4 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 6,570,392 shares of MIRM stock, worth $349 Million. This represents 16.29% of its overall portfolio holdings.
Number of Shares
6,570,392
Previous 6,570,392
-0.0%
Holding current value
$349 Million
Previous $256 Million
6.03%
% of portfolio
16.29%
Previous 13.79%
Shares
7 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Janus Henderson Group PLC London, X04.58MShares$244 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$172 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$149 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$139 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$129 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.95B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...